Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 12
1967 15
1968 19
1969 30
1970 40
1971 33
1972 31
1973 49
1974 56
1975 38
1976 41
1977 44
1978 38
1979 40
1980 33
1981 52
1982 49
1983 56
1984 44
1985 45
1986 46
1987 49
1988 51
1989 59
1990 71
1991 53
1992 56
1993 53
1994 41
1995 68
1996 71
1997 36
1998 56
1999 44
2000 67
2001 89
2002 77
2003 102
2004 100
2005 116
2006 132
2007 134
2008 186
2009 211
2010 246
2011 303
2012 322
2013 332
2014 380
2015 419
2016 460
2017 429
2018 353
2019 165
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

5,496 results
Results by year
Filters applied: . Clear all
Page 1
'Acute myeloid leukemia: a comprehensive review and 2016 update'.
De Kouchkovsky I and Abdul-Hay M. Blood Cancer J 2016 - Review. PMID 27367478 Free PMC article.
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 000 cases per year in the United States alone. Large chromosomal translocations as well as mutations in the genes involved in hematopoietic proliferation and differentiation result in the accumulation of poorly differentiated myeloid cells. ...
Acute myeloid leukemia (AML) is the most common acute leukemia in adults, with an incidence of over 20 00
Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.
Chen X and Cherian S. Clin Lab Med 2017 - Review. PMID 29128067
Flow cytometry plays an indispensible role in the diagnosis and subclassification of acute myeloid leukemia (AML). Using a multiparametric approach, flow cytometry immunophenotyping has the advantage of efficiency with high sensitivity. ...Also discussed are diagnostic immunophenotypic features of hard-to-classify entities considered within the differential diagnosis of AML. ...
Flow cytometry plays an indispensible role in the diagnosis and subclassification of acute myeloid leukemia (AML …
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
O'Donnell MR, et al. J Natl Compr Canc Netw 2017. PMID 28687581
Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. ...
Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the
Frontline treatment of acute myeloid leukemia in adults.
Tamamyan G, et al. Crit Rev Oncol Hematol 2017 - Review. PMID 28109402 Free PMC article.
Recent years have highlighted significant progress in understanding the underlying genetic and epigenetic signatures of acute myeloid leukemia(AML). ...Compared with the historical 5-to 10-year survival rate of 10%, the survival of patients who undergo modern treatment approaches reaches up to 40-50%, and for specific subsets, the improvements are even more dramatic; for example, in acute promyelocytic leukemia, the use of all-trans retinoic acid and arsenic trioxide improved survival from 30 to 40% up to 80 to 90%. ...
Recent years have highlighted significant progress in understanding the underlying genetic and epigenetic signatures of acute myel
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance.
Grimwade D, et al. Blood 2016 - Review. PMID 26660431 Free PMC article.
Recent major advances in understanding the molecular basis of acute myeloid leukemia (AML) provide a double-edged sword. Although defining the topology and key features of the molecular landscape are fundamental to development of novel treatment approaches and provide opportunities for greater individualization of therapy, confirmation of the genetic complexity presents a huge challenge to successful translation into routine clinical practice. ...The reward of identifying AML-defining molecular lesions present in all leukemic populations (including subclones) has been exemplified by acute promyelocytic leukemia, where successful targeting of the underlying PML-RARα oncoprotein has eliminated the need for chemotherapy for disease cure. ...
Recent major advances in understanding the molecular basis of acute myeloid leukemia (AML) provide a double-edged sword …
Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
Suguna E, et al. Cardiovasc Hematol Disord Drug Targets 2018 - Review. PMID 29766829
BACKGROUND & OBJECTIVE: Acute Myeloid Leukemia (AML) is characterized by the accumulation of ≥20% myeloid premature blast cells in the bone marrow and they are most often found in the peripheral blood. ...In the western world, leukemia is one of the most common among all cancers. India is ranked 3rd in cancer disease after United States of America and China. ...
BACKGROUND & OBJECTIVE: Acute Myeloid Leukemia (AML) is characterized by the accumulation of ≥20% myeloid pr …
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.
Creutzig U, et al. Blood 2012 - Review. PMID 22879540
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a life-threatening malignancy in children, with current survival rates of ∼70%. ...The primary goal of an international expert panel of the International BFM Study Group AML Committee was to set standards for the management, diagnosis, response assessment, and treatment in childhood AML. ...
Despite major improvements in outcome over the past decades, acute myeloid leukemia (AML) remains a life-threatening ma …
[II.Acute Myeloid Leukemia].
Asou N. Gan To Kagaku Ryoho 2017. PMID 28536333 Japanese.
Hereditary Myelodysplastic Syndrome and Acute Myeloid Leukemia: Diagnosis, Questions, and Controversies.
Akpan IJ, et al. Curr Hematol Malig Rep 2018 - Review. PMID 30259338
PURPOSE OF REVIEW: To review the diagnosis of individuals with hereditary hematopoietic malignancies (HHMs) that predispose to myelodysplastic syndrome and acute myeloid leukemia, barriers to HHM diagnosis, and unaddressed questions and controversies within the HHM field. ...HHM phenotypes are diverse, but may be categorized as "purely" myeloid syndromes, syndromes with abnormal platelet number/function, and HHMs with additional organ system involvement. ...
PURPOSE OF REVIEW: To review the diagnosis of individuals with hereditary hematopoietic malignancies (HHMs) that predispose to myelod …
Systematic reviews of economic burden and health-related quality of life in patients with acute myeloid leukemia.
Bosshard R, et al. Cancer Treat Rev 2018 - Review. PMID 30098484
BACKGROUND: Acute myeloid leukemia (AML) is a rare hematologic malignancy largely affecting older adults. Comorbidities may compromise fitness and eligibility for high-intensity chemotherapy (HIC). ...
BACKGROUND: Acute myeloid leukemia (AML) is a rare hematologic malignancy largely affecting older adults. Comorbidities …
5,496 results
Jump to page
Feedback